CNTA — CENTESSA PHARMACEUTICALS PLC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 2 SEC-registered investment managers reported holding CNTA (CENTESSA PHARMACEUTICALS PLC) in their latest 13F filings, with a combined reported value of $1.01M across 153.30K shares. That is +231.5% by share count (+89.60K shares) versus the previous quarter, while reported value moved -100.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 1 added to existing stakes, 170 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of CENTESSA PHARMACEUTICALS PLC (CNTA) include Medicxi Ventures Management (Jersey) Ltd, Avoro Capital Advisors LLC, Index Venture Life Associates VI Ltd, ranked by reported 13F value among the 271 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q2 2026 | 2 | 153.30K | $1.01M | +231.5% |
| Q1 2026 | 171 | 153.46M | $6.09B | -6.1% |
| Q4 2025 | 156 | 156.37M | $3.81B | +7.4% |
| Q3 2025 | 133 | 138.24M | $3.23B | +2.1% |
| Q2 2025 | 128 | 134.17M | $1.68B | +2.7% |
| Q1 2025 | 136 | 131.83M | $1.82B | -1.8% |
| Q4 2024 | 114 | 126.89M | $2.03B | +6.9% |
| Q3 2024 | 106 | 111.79M | $1.71B | +15.0% |
Over the 8 quarters shown, institutional share counts decreased 100% in aggregate (Q3 2024 → Q2 2026); the largest single-quarter swing was Q3 2024 (+15.0%).
Top Institutional Holders (Q2 2026) — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 25.00K | $1.01M | 0.25% | New | |
| 128.30K | $231 | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 19.96M | $792.94M | 80.76% | Hold | |
| 11.43M | $454.02M | 5.52% | Reduce | |
| 9.96M | $395.68M | 100.00% | Hold | |
| 8.93M | $354.50M | 0.55% | Reduce | |
| 8.17M | $324.51M | 4.42% | New | |
| 6.85M | $272.16M | 0.01% | Reduce | |
| 5.26M | $208.88M | 4.39% | Add | |
| 4.83M | $191.95M | 0.03% | Add | |
| 4.83M | $191.95M | 0.03% | Add | |
| 4.81M | $191.01M | 1.25% | Reduce | |
| 4.81M | $191.01M | 1.14% | Reduce | |
| 4.29M | $170.26M | 4.87% | Hold | |
| 4.27M | $169.54M | 0.01% | Add | |
| 3.57M | $141.96M | 2.90% | New | |
| 3.49M | $138.74M | 0.07% | Reduce | |
| 3.16M | $125.44M | 2.05% | Add | |
| 2.12M | $84.41M | 4.47% | Add | |
| 2.05M | $81.59M | 0.81% | Add | |
| 2.05M | $81.40M | 0.13% | Reduce | |
| 1.99M | $78.91M | 2.99% | Reduce | |
| 1.93M | $76.76M | 0.01% | Add | |
| 1.85M | $73.66M | 0.85% | Add | |
| 1.85M | $73.66M | 0.88% | Add | |
| 1.56M | $62.00M | 5.56% | Reduce | |
| 1.40M | $55.61M | 2.99% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 19.96M | $499.28M | 59.80% | Hold | |
| 14.56M | $364.03M | 4.01% | Add | |
| 11.28M | $282.16M | 0.43% | Add | |
| 9.96M | $249.14M | 100.00% | Hold | |
| 8.96M | $224.14M | 0.01% | Add | |
| 6.12M | $153.00M | 5.33% | Reduce | |
| 5.38M | $134.48M | 0.64% | Add | |
| 5.38M | $134.48M | 0.58% | Add | |
| 4.29M | $107.20M | 3.55% | Add | |
| 4.09M | $102.39M | 0.05% | Reduce | |
| 4.03M | $100.73M | 3.00% | Add | |
| 3.93M | $98.22M | 0.01% | Reduce | |
| 3.12M | $77.91M | 3.67% | Add | |
| 2.92M | $72.97M | 1.38% | Reduce | |
| 2.37M | $59.23M | 0.02% | Reduce | |
| 2.34M | $58.58M | 0.10% | Add | |
| 2.28M | $57.00M | 4.36% | Reduce | |
| 2.19M | $54.73M | 1.87% | New | |
| 2.00M | $50.02M | 0.89% | New | |
| 1.87M | $46.79M | 0.02% | Add | |
| 1.87M | $46.79M | 0.07% | Add | |
| 1.79M | $44.79M | 0.45% | Reduce | |
| 1.64M | $41.11M | 0.44% | New | |
| 1.64M | $41.11M | 0.45% | New | |
| 1.36M | $34.11M | 10.31% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 19.96M | $484.11M | 65.03% | Hold | |
| 10.81M | $262.10M | 3.89% | Add | |
| 10.04M | $243.35M | 0.39% | Add | |
| 9.96M | $241.57M | 100.00% | Hold | |
| 9.68M | $234.78M | 7.05% | Hold | |
| 6.28M | $152.22M | 0.01% | Add | |
| 5.41M | $131.08M | 0.06% | Reduce | |
| 4.80M | $116.50M | 0.01% | Reduce | |
| 4.33M | $105.03M | 0.43% | Reduce | |
| 4.33M | $105.03M | 0.43% | Reduce | |
| 3.64M | $88.17M | 8.31% | Reduce | |
| 3.23M | $78.27M | 3.06% | Reduce | |
| 3.14M | $76.06M | 3.74% | Add | |
| 3.10M | $75.20M | 2.27% | Add | |
| 2.85M | $69.11M | 3.37% | Reduce | |
| 2.56M | $62.04M | 0.02% | Add | |
| 2.29M | $55.57M | 0.69% | Add | |
| 1.93M | $46.68M | 3.22% | Reduce | |
| 1.75M | $42.43M | 0.07% | New | |
| 1.31M | $31.86M | 12.31% | Add | |
| 1.12M | $27.27M | 0.00% | Reduce | |
| 1.11M | $26.85M | 2.59% | Add | |
| 1.10M | $26.60M | 0.01% | Reduce | |
| 1.07M | $26.01M | 0.10% | Reduce | |
| 952.27K | $23.09M | 0.01% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 19.96M | $262.32M | 61.40% | Hold | |
| 9.96M | $130.90M | 100.00% | Hold | |
| 9.68M | $127.22M | 3.50% | Hold | |
| 8.40M | $110.42M | 0.19% | Add | |
| 6.53M | $85.82M | 0.04% | Add | |
| 5.91M | $77.63M | 0.01% | Add | |
| 5.00M | $65.70M | 1.15% | Add | |
| 4.53M | $59.52M | 0.25% | Add | |
| 4.53M | $59.52M | 0.26% | Add | |
| 4.29M | $56.42M | 7.31% | Reduce | |
| 3.83M | $50.28M | 0.00% | Hold | |
| 3.46M | $45.46M | 2.35% | Add | |
| 3.30M | $43.34M | 3.06% | Add | |
| 2.89M | $37.99M | 4.34% | Hold | |
| 2.59M | $34.05M | 0.17% | Add | |
| 2.54M | $33.42M | 0.01% | Hold | |
| 2.09M | $27.42M | 2.04% | Reduce | |
| 1.79M | $23.57M | 0.00% | Reduce | |
| 1.72M | $22.62M | 0.01% | Add | |
| 1.53M | $20.10M | 0.29% | Add | |
| 1.27M | $16.63M | 6.06% | Add | |
| 1.25M | $16.47M | 9.26% | Hold | |
| 1.22M | $16.05M | 0.06% | New | |
| 1.15M | $15.07M | 0.56% | Reduce | |
| 1.13M | $14.86M | 0.01% | Add |
Q1 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 19.96M | $287.07M | 65.59% | Hold | |
| 9.96M | $143.25M | 100.00% | Hold | |
| 9.68M | $139.22M | 4.67% | Hold | |
| 6.95M | $100.00M | 0.18% | Add | |
| 5.92M | $86.39M | 0.05% | Add | |
| 5.34M | $76.82M | 0.01% | Hold | |
| 4.87M | $70.09M | 8.00% | Reduce | |
| 4.33M | $62.33M | 0.30% | Add | |
| 4.33M | $62.33M | 0.35% | Add | |
| 4.05M | $58.24M | 0.91% | New | |
| 3.83M | $55.02M | 0.00% | Add | |
| 3.04M | $43.72M | 1.63% | Reduce | |
| 2.96M | $42.57M | 2.40% | Reduce | |
| 2.94M | $42.24M | 0.00% | Add | |
| 2.89M | $41.57M | 5.67% | Hold | |
| 2.54M | $36.55M | 0.01% | Add | |
| 2.37M | $34.05M | 2.51% | Add | |
| 2.29M | $32.88M | 0.18% | Reduce | |
| 2.26M | $32.52M | 2.67% | Reduce | |
| 2.26M | $32.44M | 0.10% | New | |
| 1.75M | $25.21M | 0.02% | Reduce | |
| 1.55M | $22.24M | 3.03% | Add | |
| 1.25M | $18.02M | 9.87% | Hold | |
| 1.23M | $17.65M | 0.20% | Hold | |
| 1.10M | $15.75M | 0.15% | Reduce |
New Positions (Q2 2026)
- SUMMIT SECURITIES GROUP LLC 25.00K sh · $1.01M
Fully Exited (vs previous quarter)
- Medicxi Ventures Management (Jersey) Ltd sold 19.96M sh · $792.94M
- Avoro Capital Advisors LLC sold 11.43M sh · $454.02M
- Index Venture Life Associates VI Ltd sold 9.96M sh · $395.68M
- ADAGE CAPITAL PARTNERS GP, L.L.C. sold 8.93M sh · $354.50M
- Pentwater Capital Management LP sold 8.17M sh · $324.51M
- Fidelity Management & Research (FMR) sold 6.85M sh · $272.16M
- PERCEPTIVE ADVISORS LLC sold 5.26M sh · $208.88M
- Capital World Investors sold 4.83M sh · $191.95M
- Capital World Investors sold 4.83M sh · $191.95M
- Farallon Capital Management sold 4.81M sh · $191.01M
- FARALLON CAPITAL MANAGEMENT, L.L.C. sold 4.81M sh · $191.01M
- TCG Crossover Management, LLC sold 4.29M sh · $170.26M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUMMIT SECURITIES GROUP LLC | 25.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SIMPLEX TRADING, LLC | 128.30K | 38.70K | — | 2.62K | 2.90K | 100 | — | 100 | — | 1.50K | 500 | 300 | — | — | — | — | — | — | — | — |
| Medicxi Ventures Management (Jersey) Ltd | — | 19.96M | 19.96M | 19.96M | 19.96M | 19.96M | 19.96M | 19.96M | 19.96M | 19.96M | 19.96M | 19.96M | — | — | — | — | — | — | — | — |
| Avoro Capital Advisors LLC | — | 11.43M | 14.56M | 10.81M | 5.00M | 4.05M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Index Venture Life Associates VI Ltd | — | 9.96M | 9.96M | 9.96M | 9.96M | 9.96M | 9.96M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | — | 8.93M | 11.28M | 10.04M | 8.40M | 6.95M | 5.12M | 4.20M | 3.12M | 2.25M | 2.90M | 2.83M | — | — | — | — | — | — | — | — |
| Pentwater Capital Management LP | — | 8.17M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | — | 6.85M | 8.96M | 6.28M | 3.83M | 3.83M | 3.65M | 2.92M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 1.23M | 1.23M | 708.79K | 10.30K | 10.30K | 94.30K | 362.74K |
| GENERAL ATLANTIC, L.P. | — | 1.35M | 6.12M | 9.68M | 9.68M | 9.68M | 9.68M | 9.68M | 9.68M | 9.68M | 9.68M | 9.68M | — | — | — | — | — | — | — | — |
| PERCEPTIVE ADVISORS LLC | — | 5.26M | 2.92M | 3.10M | 1.15M | 3.04M | 6.35M | 6.28M | 3.93M | 3.08M | — | — | — | — | — | — | — | — | — | — |
| Capital World Investors | — | 4.83M | 1.16M | 684.80K | 416.82K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Capital World Investors | — | 4.83M | 1.16M | 684.80K | 416.82K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Farallon Capital Management | — | 4.81M | 5.38M | 4.33M | 4.53M | 4.33M | 3.50M | 2.81M | 2.00M | 371.00K | — | — | — | — | — | — | — | — | — | — |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | — | 4.81M | 5.38M | 4.33M | 4.53M | 4.33M | 3.50M | 2.81M | 2.00M | 371.00K | — | — | — | — | — | — | — | — | — | — |
| TCG Crossover Management, LLC | — | 4.29M | 4.29M | 3.14M | 2.89M | 2.89M | 2.89M | 2.89M | 2.89M | 2.04M | 2.04M | 2.04M | — | — | — | — | — | — | — | — |
| Morgan Stanley | — | 4.27M | 1.11M | 1.12M | 1.79M | 2.94M | 1.92M | 1.38M | 2.05M | 2.14M | 1.21M | 957.95K | 824.63K | 743.91K | 315.13K | 16.49K | 40.26K | 21.61K | 14.09K | 7.63K |
| Paradigm Biocapital Advisors LP | — | 3.57M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Janus Henderson Group | — | 3.49M | 4.09M | 5.41M | 6.53M | 5.92M | 4.91M | 1.29M | — | — | — | — | — | — | 2.11M | 2.94M | 3.43M | 5.62M | 5.74M | 5.61M |
| Deep Track Capital, LP | — | 3.16M | 2.00M | — | 500.00K | — | 1.35M | 1.35M | — | — | — | — | — | — | — | — | — | — | — | — |
| PRICE T ROWE ASSOCIATES INC /MD/ | — | — | 3.93M | 4.80M | 5.91M | 5.34M | 5.36M | 4.68M | 3.53M | 2.96M | 2.54M | 2.55M | — | — | — | — | — | — | — | — |
FAQ
Which funds hold CNTA?
As of 2026-Q2, 2 institutional funds reported holding CNTA (CENTESSA PHARMACEUTICALS PLC) in SEC 13F filings, with a combined reported value of $1.01M.
How many shares of CNTA do institutions own?
13F filers reported 153.30K shares of CNTA, worth $1.01M in aggregate at the end of 2026-Q2.
Is institutional ownership of CNTA rising or falling?
Share counts moved +231.5% versus the prior quarter — accumulation.
Who are the top institutional holders of CNTA?
The largest 13F holders are Medicxi Ventures Management (Jersey) Ltd, Avoro Capital Advisors LLC, Index Venture Life Associates VI Ltd, ADAGE CAPITAL PARTNERS GP, L.L.C., Pentwater Capital Management LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of CENTESSA PHARMACEUTICALS PLC?
The major shareholders of CENTESSA PHARMACEUTICALS PLC (CNTA) by reported 13F value are Medicxi Ventures Management (Jersey) Ltd, Avoro Capital Advisors LLC, Index Venture Life Associates VI Ltd, ADAGE CAPITAL PARTNERS GP, L.L.C., Pentwater Capital Management LP, among 271 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.